Literature DB >> 2355198

C4B deficiency: a risk factor for bacteremia with encapsulated organisms.

N A Bishof1, T R Welch, L S Beischel.   

Abstract

The fourth component of complement (C4) is crucial to the activation of the classical complement pathway, a key defense against invading microorganisms. The two isotypes of C4, C4A and C4B, have very different in vitro activities. An increased incidence of total C4B deficiency was found in white patients with Streptococcus pneumoniae, Haemophilus influenzae, or Neisseria meningitidis infection (14% of bacteremic children vs. 2% of race-matched controls, P = .02). In black patients, however, there was no difference in incidence of C4B deficiency between bacteremic patients and race-matched controls (7% and 5%, respectively, P greater than .5). These data suggest that, at least in whites, total C4B deficiency is a risk factor for invasive disease with these three encapsulated organisms.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2355198     DOI: 10.1093/infdis/162.1.248

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  27 in total

Review 1.  Complement deficiency.

Authors:  K M O'Neil
Journal:  Clin Rev Allergy Immunol       Date:  2000-10       Impact factor: 8.667

Review 2.  Clinical implications of the specialised B cell response to polysaccharide encapsulated pathogens.

Authors:  C G Vinuesa; C de Lucas; M C Cook
Journal:  Postgrad Med J       Date:  2001-09       Impact factor: 2.401

3.  A unique recombination event resulting in a C4A*Q0,C4B*Q0 double null haplotype.

Authors:  M B Fasano; J A Winkelstein; T LaRosa; W B Bias; R H McLean
Journal:  J Clin Invest       Date:  1992-10       Impact factor: 14.808

4.  Genotypic diversity of complement component C4 does not predict kidney transplant outcome.

Authors:  Markus Wahrmann; Bernd Döhler; Andrea Ruhenstroth; Helmuth Haslacher; Thomas Perkmann; Markus Exner; Andrew J Rees; Georg A Böhmig
Journal:  J Am Soc Nephrol       Date:  2010-12-16       Impact factor: 10.121

5.  Circulating immune complexes and complement C4 null alleles in patients in patients operated on for premature atherosclerotic peripheral vascular disease.

Authors:  S Nityanand; L Truedsson; A Mustafa; C Bergmark; A K Lefvert
Journal:  J Clin Immunol       Date:  1999-11       Impact factor: 8.317

6.  Structural differences between the two human complement C4 isotypes affect the humoral immune response.

Authors:  O Finco; S Li; M Cuccia; F S Rosen; M C Carroll
Journal:  J Exp Med       Date:  1992-02-01       Impact factor: 14.307

7.  Complement 4 phenotypes and genotypes in Brazilian patients with classical 21-hydroxylase deficiency.

Authors:  G Guerra-Junior; A Sevciovic Grumach; S H Valente de Lemos-Marini; M Kirschfink; A Condino Neto; M de Araujo; M Palandi De Mello
Journal:  Clin Exp Immunol       Date:  2009-02       Impact factor: 4.330

8.  Defining targets for complement components C4b and C3b on the pathogenic neisseriae.

Authors:  Lisa A Lewis; Sanjay Ram; Alpana Prasad; Sunita Gulati; Silke Getzlaff; Anna M Blom; Ulrich Vogel; Peter A Rice
Journal:  Infect Immun       Date:  2007-11-05       Impact factor: 3.441

9.  Association of C4B deficiency (C4B*Q0) with erythema nodosum in leprosy.

Authors:  I J de Messias; J Santamaria; M Brenden; A Reis; G Mauff
Journal:  Clin Exp Immunol       Date:  1993-05       Impact factor: 4.330

10.  Determining the one, two, three, or four long and short loci of human complement C4 in a major histocompatibility complex haplotype encoding C4A or C4B proteins.

Authors:  Erwin K Chung; Yan Yang; Kristi L Rupert; Karla N Jones; Robert M Rennebohm; Carol A Blanchong; C Yung Yu
Journal:  Am J Hum Genet       Date:  2002-09-10       Impact factor: 11.025

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.